SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests 'Off-the-Shelf' cell therapy for Tough-to-Treat cancers
Disease control Not yet recruitingThis is the first time a new cell therapy called NEUK203-13 Injection is being tested in people. The study aims to see if it is safe and can help control tumors in patients with advanced small cell lung cancer or other neuroendocrine tumors that have stopped responding to standar…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Three-Pronged attack on aggressive lung cancer
Disease control Not yet recruitingThis study is testing whether adding two newer drugs (bemotuzumab and anlotinib) to standard chemotherapy and radiation can better control extensive-stage small cell lung cancer. About 25 patients who haven't had prior treatment will receive the combination therapy in phases, sta…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Major study tracks new Drug's fight against aggressive lung cancer
Disease control Not yet recruitingThis study will observe how well the immunotherapy drug toripalimab works in real-world treatment for patients with advanced small cell lung cancer. Researchers will follow about 1200 patients already scheduled to receive this drug as their first treatment, tracking how long the …
Matched conditions: SCLC, EXTENSIVE STAGE
Sponsor: Fudan University • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug tested for Tough-to-Treat lung cancer
Disease control Not yet recruitingThis study is testing an experimental drug called IBI363 in people with advanced small cell lung cancer that has continued to grow despite previous treatments, including immunotherapy. The trial will enroll 35 patients to see how well the drug shrinks tumors and how safe it is. P…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can a lung cancer drug still fight back after failing?
Disease control Not yet recruitingThis study looks back at medical records to see if continuing the drug anlotinib helps control advanced lung cancer, even after the cancer has started growing again. It will include about 350 people with specific types of lung cancer who kept taking anlotinib or switched to other…
Matched conditions: SCLC, EXTENSIVE STAGE
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC